Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.34, $0.21 better than the analyst estimate of $1.13. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.49 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2018 EPS of $5.10-$5.20, versus the consensus of $4.88.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.